Optic atrophy type 1
Last updated 8 Nov 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Optic atrophy type 1 is a condition that often causes slowly worsening vision, usually beginning in childhood. People with optic atrophy type 1 typically experience a narrowing of their field of vision (tunnel vision). Affected individuals gradually lose their sight as their field of vision becomes smaller. Both eyes are usually affected equally, but the severity of the vision loss varies widely, even among affected members of the same family, ranging from nearly normal vision to complete blindness.
Video picks for Genetic conditionsVideo library
Description
Optic atrophy type 1 is a condition that often causes slowly worsening vision, usually beginning in childhood. People with optic atrophy type 1 typically experience a narrowing of their field of vision (tunnel vision). Affected individuals gradually lose their sight as their field of vision becomes smaller. Both eyes are usually affected equally, but the severity of the vision loss varies widely, even among affected members of the same family, ranging from nearly normal vision to complete blindness.
In addition to vision loss, people with optic atrophy type 1 frequently have problems with colour vision (colour vision deficiency) that make it difficult or impossible to distinguish between shades of blue and green.
In the early stages of the condition, individuals with optic atrophy type 1 experience a progressive loss of certain cells within the retina, which is a specialized light-sensitive tissue that lines the back of the eye. The loss of these cells (known as retinal ganglion cells) is followed by the degeneration (atrophy) of the nerves that relay visual information from the eye to the brain (optic nerves), which results in further vision loss. Atrophy causes these nerves to have an abnormally pale appearance (pallor), which can be seen during an eye examination.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
ADOA
Autosomal dominant optic atrophy
Autosomal dominant optic atrophy Kjer type
DOA
Dominant optic atrophy
Kjer type optic atrophy
Kjer's optic atrophy
Optic atrophy, autosomal dominant
Optic atrophy, hereditary, autosomal dominant
Optic atrophy, juvenile
Optic atrophy, Kjer type
Patient picks for Genetic conditions

Diabetes
Type 1 diabetes
Type 1 diabetes is the type of diabetes that typically develops in children and in young adults. In type 1 diabetes the body stops making insulin and the blood sugar (glucose) level goes very high. Treatment to control the blood glucose level is with insulin injections and a healthy diet. Other treatments aim to reduce the risk of complications. They include reducing blood pressure if it is high and advice to lead a healthy lifestyle.
by Dr Colin Tidy, MRCGP

Diabetes
Type 2 diabetes
Type 2 diabetes can occur at any age, including during childhood, but it occurs mainly in people aged over 40. The first-line treatment is diet, weight control and physical activity. The good news is that many people can stay well using these lifestyle measures. However if the blood sugar (glucose) level remains high then tablets to reduce the blood glucose level are usually advised. Insulin injections are needed in some cases. Other treatments include reducing blood pressure if it is high, lowering high cholesterol levels, and also other measures to reduce the risk of complications.
by Dr Colin Tidy, MRCGP

Health and wellness video library
Type 2 diabetes videos
Our type 2 diabetes video hub features expert-led videos covering everything you need to know—from what causes type 2 diabetes and its common symptoms, to how it’s treated and the possible complications to watch out for. Whether you’re newly diagnosed or supporting someone with the condition, these videos are here to help you take control and live well.
by Lawrence Higgins

Diabetes
Video: What's the difference between type 1 and type 2 diabetes?
While they're both technically under the umbrella of diabetes, type 1 and type 2 are very different conditions which require a distinct set of treatments. We've looked at some of the main questions people have around each.
by Dr Sarah Jarvis

Diabetes
Continuous glucose monitoring in type 1 diabetes
Type 1 and type 2 diabetes are both potentially serious conditions which should always be taken seriously. They’re both diagnosed on the basis of high blood sugar. But in other respects they are very, very different. Type 2 is largely down to lifestyle – getting type 1 is absolutely nothing to do with whether you eat too much sugar, carry excess weight or don’t exercise enough. People with type 2 diabetes often never need insulin – those with type 1 need it from day one. Many people with type 2 diabetes never need treatment that carries a risk of disabling low blood sugar (hypoglycaemia) – people with type 1 live with this risk every day. As a result, many people with type 2 never need to check their blood sugar several times a day – for people with type 1, it’s a highly unwelcome occupational hazard.
by Dr Sarah Jarvis

Diabetes
Slowdown in type 2 diabetes cases
Some countries have seen a fall in new cases of type 2 diabetes according to a new review of the current evidence.
by Milly Evans
Related patient information and medicines

Patient information leaflet
Eye problems
This leaflet contains a list of conditions which affect the eye, grouped together by the part of the eye which is affected or involved. See the leaflet called Anatomy of the eye for details on the structure of the eye Anatomy of the eye. This leads to. Optic atrophy Optic atrophy is the loss of some or all of the nerve fibres in the optic nerve..

Patient information leaflet
Diabetes
There are two main types of diabetes - type 1 diabetes and type 2 diabetes. Type 1 usually first develops in children or in young adults. LADA is sometimes called 'type 1.5 diabetes', because it has similarities to both type 1 and type 2 diabetes and is sometimes thought of as an 'in-between' condition. It is also called DIDMOAD (because it causes.

Patient information leaflet
Type 1 diabetes
Type 1 diabetes is the type of diabetes that typically develops in children and in young adults. In type 1 diab... Treatment of complications Too much insulin can make the blood glucose level go too low ( hypoglycaemia Hypoglycaemia , sometimes called a 'hypo'). See the separate leaflets called Diabetic Neuropathy Diabetic neuropathy and Diabetic.

Patient information leaflet
Acute angle-closure glaucoma
Acute angle-closure glaucoma is a serious eye condition that occurs when the fluid pressure inside the eye rises quickly, leading to sudden, severe eye pain, a red eye and reduced or blurred vision. It is a medical emergency. What is acute angle glaucoma? | Patient Explainers Acute angle-closure glaucoma is a serious eye condition that occurs when.

Patient information leaflet
Macular degeneration
Age-related macular degeneration is the most common cause of sight impairment in those aged over 50. It causes a gradual loss of central vision, w... Macular degeneration (also known as age-related macular degeneration) occurs when cells in the macula - the central area of the retina - degenerate. Dry macular degeneration This is the most common.

Patient information leaflet
Visual problems
Visual problems can arise from problems affecting different parts of the eye. Generally speaking, the further towards the back of the eye that problems occur, the more likely they are to have a long-lasting or permanent effect on your eyesight. Side View of the Eye Side View of the Eye The lens of the eye acts like the lens in a camera. Nerve.
Further reading and references
- Optic atrophy type 1; MedlinePlus, National Library of Medicine.
- Delettre-Cribaillet C, Hamel CP, Lenaers G. Optic Atrophy Type 1 - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2007 Jul 13 [updated 2015 Nov 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1248/
- Ferre M, Bonneau D, Milea D, Chevrollier A, Verny C, Dollfus H, Ayuso C, Defoort S, Vignal C, Zanlonghi X, Charlin JF, Kaplan J, Odent S, Hamel CP, Procaccio V, Reynier P, Amati-Bonneau P. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat. 2009 Jul;30(7):E692-705. doi: 10.1002/humu.21025.
- Formichi P, Radi E, Giorgi E, Gallus GN, Brunetti J, Battisti C, Rufa A, Dotti MT, Franceschini R, Bracci L, Federico A. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene. J Neurol Sci. 2015 Apr 15;351(1-2):99-108. doi: 10.1016/j.jns.2015.02.047. Epub 2015 Mar 6.
- Roubertie A, Leboucq N, Picot MC, Nogue E, Brunel H, Le Bars E, Manes G, Angebault Prouteau C, Blanchet C, Mondain M, Chevassus H, Amati-Bonneau P, Sarzi E, Pages M, Villain M, Meunier I, Lenaers G, Hamel CP. Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction. J Neurol Sci. 2015 Feb 15;349(1-2):154-60. doi: 10.1016/j.jns.2015.01.008. Epub 2015 Jan 13.
- Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, Ah-Kine D, Hudson G, Czermin B, Taylor RW, Horvath R, Chinnery PF. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010 Aug;117(8):1538-46, 1546.e1. doi: 10.1016/j.ophtha.2009.12.038. Epub 2010 Apr 24.
- Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain. 2008 Feb;131(Pt 2):352-67. doi: 10.1093/brain/awm335.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

